Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF (SMAC AF)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Nova Scotia Health Research Foundation
Information provided by (Responsible Party):
Ratika Parkash, Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT00438113
First received: February 7, 2007
Last updated: June 6, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)